NOVEL OXADIAZOLE COMPOUNDS

摘要

Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the SIP family of G protein-coupled receptors for treating diseases associated with modulation of SIP family receptor activity, in particular by affording a beneficial immunosuppressive effect are disclosed.